Preparation and evaluation of fast-dissolving films of etilefrine hydrochloride for practical buccal dosing.

Etilefrine hydrochloride (ET) is an important drug in the treatment of hypotension, and parenteral injections and oral tablets are the conventional dosage forms. However, parenteral injections may cause abnormally high plasma levels as well as pain and necrosis, and oral tablets undergo first-pass metabolism. Although fast-dissolving buccal tablets were previously reported, the initial absorption rate was a little slow and the plasma levels were varied extensively. Recently, many films have been developed as novel dosage forms. Therefore, in the present study, film dosage forms containing ET were produced using water-soluble polymers and glycerin (GLY) as excipients to obtain a practical buccal dosage form. Films composed of ET, GLY, and sodium alginate (AL) exhibited good physical characteristics and rapid release in vitro (more than 70% at 2 min). The compacted AL film containing 2 mg ET (1 × 1 cm) exhibited rapid absorption (>19 ng/mL at 0.5 h), maintained an effective plasma level (>7 ng/mL) for a long time period (0.5-4 h), and had an adequate plasma concentration-time profile with a smaller standard error (<15.3 ng/mL). These results suggest that the present compacted buccal film is a superior dosage form of ET for practical use.

Preparation of orally fast-dissolving tablets of etilefrine hydrochloride to achieve efficient absorption.

Etilefrine hydrochloride (ET) is commonly used in the treatment of hypotension in dosage forms of oral tablets and parenteral injections. However, oral tablets only temporarily achieve high plasma levels and have low bioavailability (BA), while intravenous injections may cause pain and necrosis around administration sites. In an attempt to overcome these limitations, the buccal delivery of ET using oral droplets has been investigated. In this study, a buccal tablet as an alternative dosage form was developed for practical use. Buccal tablets were prepared by the direct compression method with sodium alginate (AL) and mannitol (MA) as excipients. Their disintegration and in vitro drug release were rapid (more than 50% being released after 3 min). Furthermore, effective plasma levels (> 5-7 ng/mL) were reached within 0.5 h of buccal administration in rats. The systemic absorption of these tablets was similar to that of buccal droplets. Therefore, the ET buccal tablets developed herein have potential as an alternative dosage form for hypotension therapy.

Spectrofluorimetric determination of certain adrenergic agonist drugs in their pure forms and pharmaceutical formulations: Content uniformity test application.

A new, simple, sensitive and rapid spectrofluorimetric method has been developed for determination of certain adrenergic agonists such as isoxsuprine hydrochloride, ritodrine hydrochloride and etilefrine hydrochloride in their pure forms and pharmaceutical dosage forms. The method depends on micellar enhancement of the native fluorescence of investigated drugs by using 2% w/v sodium dodecyl sulfate (SDS) as an anionic surfactant. The enhanced fluorescence intensity of investigated drugs was measured at 305 nm after excitation at 278 nm. The interaction of studied drugs with SDS was studied, and the enhanced fluorescence intensity was exploited to develop an assay method for the determination of investigated drugs. The relative fluorescence intensity-concentration plots were rectilinear over the range 0.15-3.00 µg ml-1 , with low quantification limits of 0.132, 0.123 and 0.118 µg mL-1 for isoxsuprine, ritodrine and etilefrine, respectively. The proposed method was successfully applied for determination of studied drugs in their pharmaceutical formulations. Moreover, the high sensitivity of the proposed method allows performing the content uniformity testing of the studied drugs in their tablets by using the official United States Pharmacopeia (USP) guidelines. Statistical comparisons of the results with those of the reported methods revealed excellent agreement and indicated no significant difference in accuracy and precision.

Sequential injection spectrophotometric determination of etilefrine hydrochloride.

A simple, fast, economical and automated sequential injection spectrophotometric method for the determination of etilefrine hydrochloride is developed. The method is based on the condensation reaction of etilefrine hydrochloride with 4-aminoantipyrine in the presence of alkaline potassium hexacyanoferrate and the absorbance of the colored product measured at 503 nm. Aspiration order, flow rate, reaction coil diameter, reaction coil length, concentration of 4-aminoantipyrine and potassium ferricyanide, as well as aspiration volume of reagents and sample has been optimized. Using these optimized parameters, a linear relationship between the relative peak height and concentration was obtained in the range 1-20 mg l(-1). The detection limit (as 3sigma value) was 0.1 mg l(-1) and precision was 2.7% and 1.5% at 1 and 2 mg l(-1), respectively. This method is superior over previously reported ones in terms of linear range, short analysis time, high sample throughput, excellent reagent economy and minimum waste generation.

Synthesis, characterization, and reactivity of ferrous and ferric oxo/peroxo pivalate complexes in relation to Gif-type oxygenation of substrates.

This study examines structural features and aspects of reactivity of Gif-type reagents, which depend on O2/Zn to mediate oxidation of hydrocarbons. The reagents investigated derive from the use of iron complexes with the anion of the weak carboxylic acid Me3CCO2H (pivalic acid (PivH)) in pyridine/PivH. In these solutions, the known compound [Fe3O(O2CCMe3)6(py)3] is reduced by Zn to generate yellow-green [FeII(O2CCMe3)2(py)4], which readily reverts to [Fe3O(O2CCMe3)6(py)3], and eventually to [Fe3O(O2CCMe3)6(py)3]+, upon exposure to dioxygen. All three species are equally well suited to mediate Gif-like oxygenation of substrates supported by O2/Zn. [FeIII3O(O2CCMe3)6(L)3]+ (L = H2O, py) is converted by H2O2 to afford the hexairon(III) peroxo compounds [Fe6(O2)(O)2(O2CCMe3)12(L)2] (L = Me3CCO2H, py), which feature a [Fe6(eta 2-mu 4-O2)(mu 3-O)2] core previously documented in the closely related [Fe6(O2)(O)2(O2CPh)12(H2O)2]. A similar peroxo species, [Fe6(O2)(O)2(O2CCMe3)2(O2CCF3)10(H2O)2], is obtained upon replacing all pivalate ligands by trifluoroacetate groups with the exception of those pivalates that bridge between the two [Fe3O(O2CCF3)5(H2O)]2+ units. The structure of the [Fe6(O2)(O)2] core in these peroxo species is found to range from a recliner to a butterfly-type conformation. Reduction of [Fe6(O2)(O)2(O2CCMe3)12(HO2CCMe3)2] with NaBH4 generates [Na2Fe4(O)2(O2CCMe3)10(L)(L')] (L = CH3CN, L' = Me2CO; L = L' = Me3CCO2H), which feature a [Na2Fe4(O)2] core possessing a bent butterfly conformation of the [Fe4(O)2] unit. Oxidation of the same peroxo complex by CeIV or NOBF4 regenerates the oxo-bridged [Fe3O(O2CCMe3)6(solv)3]+ (solv = EtOH, H2O, thf). Employment of the sterically encumbered 2-Me-5-Etpyridine provides the tetrairon compound [Fe4(O)2(O2CCMe3)8(2-Me-5-Etpy)2], which can be readily transformed upon treatment with H2O2 to the asymmetric peroxo complex [Fe6(O2)(O)2(O2CCMe3)12(2-Me-5-Etpy)2]. The peroxo-containing complexes oxidize both cis-stilbene and adamantane in either benzene or py/PivH, but only under forceful conditions and at very low yields. The low reactivity and high selectivity (tert/sec = 8) obtained in the oxidation of adamantane suggests that the present type of peroxo species is not directly involved in catalytic Gif-type oxygenations of adamantane.